GATA5

Chr 20ADAR

GATA binding protein 5

Also known as: CHTD5, GATAS, bB379O24.1

GATA5 encodes a transcription factor containing two GATA-type zinc fingers that is required during cardiovascular development and plays an important role in smooth muscle cell diversity. Mutations cause multiple types of congenital heart defects with both autosomal dominant and autosomal recessive inheritance patterns reported. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.629), consistent with its role in essential cardiac development.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Congenital heart defects, multiple types, 5MIM #617912
ADAR
0
Active trials
17
Pubs (1 yr)
1
P/LP submissions
P/LP missense
0.63
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryGATA5
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.
📋
ClinVar Variants
1 unique Pathogenic / Likely Pathogenic· 185 VUS of 300 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.63LOEUF
pLI 0.285
Z-score 2.46
OE 0.24 (0.110.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.07Z-score
OE missense 0.78 (0.680.89)
146 obs / 187.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.110.63)
00.351.4
Missense OE0.78 (0.680.89)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 3 / 12.3Missense obs/exp: 146 / 187.3Syn Z: -0.03
DN
0.6164th %ile
GOF
0.3689th %ile
LOF
0.70top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median
DN1 literature citation

Literature Evidence

DNThe expression of the mutant inhibited wild-type-induced activation of the ANF promoter, suggesting that the mutant functions in a dominant-negative manner.PMID:22961344

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

300 submitted variants in ClinVar

Classification Summary

Pathogenic1
VUS185
Likely Benign109
Conflicting2
1
Pathogenic
185
VUS
109
Likely Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
0
0
0
0
0
VUS
12
160
13
0
185
Likely Benign
0
1
31
77
109
Benign
0
0
0
0
0
Conflicting
2
Total121614577297

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GATA5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗